C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2650326
The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus.
La présente invention concerne l'utilisation de dérivés de N-(2-thiazolyl)-amides représentés par la formule (I) pour le traitement et/ou la prévention d'une maladie induite par la glycogène synthase kinase 3 (GSK-3), en particulier des maladies neurodégénératives, telles que la maladie d'Alzheimer ou le diabète non insulinodépendant.
Alonso Cascon Mercedes
Castro Morera Ana
Del Monte Millan Maria
Fuertes Huerta Ana
Martin Aparicio Ester
Noscira S.a.
Perry + Currier
LandOfFree
N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1994093